Product Name |
Levodopa D3 |
Alternate Names |
Levodopa Stable Isotopes, Stable Isotopes of Levodopa |
CAT No. |
CS-O-02700
|
CAS No. |
53587-29-4 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
200.21 g/mol |
Mol. For. |
C₉H₈D₃NO₄
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Levodopa |
Purity |
95% |
Therapeutic |
Anti-Parkinsons |
Smileys |
N[C@H](C(O)=O)CC(C([2H])=C1[2H])=C(C(O)=C1O)[2H] |
Canonical Smiles |
C1=CC(=C(C=C1CC(C(=O)O)N)O)O |
InchIKey |
WTDRDQBEARUVNC-UOCCHMHCSA-N |
Inchl |
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1/i1D,2D,4D |
IUPAC |
(2S)-2-amino-3-(2,3,6-trideuterio-4,5-dihydroxyphenyl)propanoic acid |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Levodopa D3 is a chemical compound that is used in the treatment of Parkinson's disease, a neurodegenerative disorder that affects the nervous system. It is a synthetic form of dopamine, a neurotransmitter that is responsible for regulating movement, mood, and other functions in the brain. Levodopa D3 works by increasing the levels of dopamine in the brain, which helps to alleviate the symptoms of Parkinson's disease.
Levodopa D3 is usually administered orally in the form of tablets or capsules. It is absorbed by the small intestine and then transported to the brain where it is converted into dopamine. The drug is usually taken several times a day, and the dosage is adjusted according to the patient's individual needs.
The chemical formula of Levodopa D3 is C9H11NO4, and it has a molecular weight of 197.19 g/mol. It is a white to off-white crystalline powder that is soluble in water and slightly soluble in ethanol. The drug is stable under normal conditions of use and storage.
There are some side effects associated with the use of Levodopa D3, including nausea, vomiting, dizziness, and hallucinations. Patients may also experience dyskinesia, a condition characterized by involuntary movements of the limbs, face, or torso. However, these side effects can usually be managed by adjusting the dosage or switching to a different medication.
In conclusion, Levodopa D3 is an important medication for the treatment of Parkinson's disease. It works by increasing the levels of dopamine in the brain and helping to alleviate the symptoms of the disease. While there are some side effects associated with the use of Levodopa D3, they can usually be managed with proper dosage adjustment and medical supervision.